These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1037 related articles for article (PubMed ID: 31140607)
1. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607 [TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma. Chen T; Zheng W; Chen J; Lin S; Zou Z; Li X; Tan Z J Cell Biochem; 2020 Oct; 121(10):4074-4084. PubMed ID: 31886566 [TBL] [Abstract][Full Text] [Related]
3. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients. Yu J; Mao W; Xu B; Chen M Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306 [TBL] [Abstract][Full Text] [Related]
4. Landscape analysis of alternative splicing in kidney renal clear cell carcinoma and their clinical significance. Cheng S; Zhou Z; Liu J; Li J; Wang Y; Xiao J; Luo Y Aging (Albany NY); 2024 Jun; 16(11):10016-10032. PubMed ID: 38862257 [TBL] [Abstract][Full Text] [Related]
5. Systematic Identification of Survival-Associated Alternative Splicing Events in Kidney Renal Clear Cell Carcinoma. Wei Y; Zhang Z; Peng R; Sun Y; Zhang L; Liu H Comput Math Methods Med; 2021; 2021():5576933. PubMed ID: 33959190 [TBL] [Abstract][Full Text] [Related]
6. Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma. Xiao L; Zou G; Cheng R; Wang P; Ma K; Cao H; Zhou W; Jin X; Xu Z; Huang Y; Lin X; Nie H; Jiang Q BMC Cancer; 2021 Jun; 21(1):703. PubMed ID: 34130646 [TBL] [Abstract][Full Text] [Related]
7. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma. Xing Q; Ji C; Zhu B; Cong R; Wang Y Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567 [TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma. Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668 [TBL] [Abstract][Full Text] [Related]
9. Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma. Duan Y; Zhang D J Cell Biochem; 2020 Jan; 121(1):672-689. PubMed ID: 31407370 [TBL] [Abstract][Full Text] [Related]
10. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma. Chen L; Xiang Z; Chen X; Zhu X; Peng X Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases. He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970 [TBL] [Abstract][Full Text] [Related]
12. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening. Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208 [TBL] [Abstract][Full Text] [Related]
13. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma. Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605 [TBL] [Abstract][Full Text] [Related]
14. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis. Hu F; Zeng W; Liu X Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma. Zhao E; Li L; Zhang W; Wang W; Chan Y; You B; Li X J Transl Med; 2019 May; 17(1):177. PubMed ID: 31133033 [TBL] [Abstract][Full Text] [Related]
16. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma. Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299 [TBL] [Abstract][Full Text] [Related]
17. An eleven metabolic gene signature-based prognostic model for clear cell renal cell carcinoma. Wu Y; Wei X; Feng H; Hu B; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Wang S; Liu J; Wang T Aging (Albany NY); 2020 Nov; 12(22):23165-23186. PubMed ID: 33221754 [TBL] [Abstract][Full Text] [Related]
18. Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma. Tang W; Cao Y; Ma X Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32633782 [TBL] [Abstract][Full Text] [Related]
19. Identification of a Set of Genes Improving Survival Prediction in Kidney Renal Clear Cell Carcinoma through Integrative Reanalysis of Transcriptomic Data. Ruan B; Feng X; Chen X; Dong Z; Wang Q; Xu K; Tian J; Liu J; Chen Z; Shi W; Wang M; Qian L; Ding Q Dis Markers; 2020; 2020():8824717. PubMed ID: 33110456 [TBL] [Abstract][Full Text] [Related]
20. Identification of prognosis-related alternative splicing events in kidney renal clear cell carcinoma. Zuo Y; Zhang L; Tang W; Tang W J Cell Mol Med; 2019 Nov; 23(11):7762-7772. PubMed ID: 31489763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]